Potential health risks of sunscreen
Sunscreen is widely acknowledged to protect against sunburn and two common forms of skin cancer associated with direct DNA damage, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). However, there is some evidence that sunscreen use can contribute to negative health outcomes. The major claims include:
- Some sunscreens only protect against UVB radiation, and not against the UVA component of the ultraviolet spectrum. Incomplete protection against the full spectrum, combined with increased time spent in the sun, can lead to an increase in the risk of developing malignant melanoma, a rarer but more deadly form of skin cancer associated with indirect DNA damage.
- Some sunscreen chemicals can penetrate into the skin and potentially cause more cell damage than they prevent.
- Reduced exposure to ultraviolet light in sunlight can contribute to Vitamin D deficiency.
These issues have precipitated various levels of disagreement over the benefits and risks of sunscreen use. Most health authorities and medical associations have concluded that, on the whole, sunscreen use is beneficial, and the industry continues to develop improved formulations that are both longer-lasting and broader-spectrum (UVA/UVB).
Studies of melanoma rates
Even though it is rare, malignant melanoma is responsible for 75% of all skin cancer-related deaths, making it the most lethal form of skin cancer. There is a correlation between high UV exposure, especially during childhood, and the risk to develop melanoma, resulting in a WHO recommendation for persons under 18 to avoid sunbeds.
Some scientists have argued that the sun-avoiding health message increases some forms of skin cancer. Malignant melanoma was found more frequently in sunscreen users compared to non-users in some studies. Other studies found that fair-skinned people used more suncreen and had more skin cancer, but did not establish a causal relationship. It was suggested that those sunscreens blocked the natural warnings and adaptations mediated by UVB, but allowed damage from UVA to go unchecked. However, these claims could not be supported in two meta-analyses, including one of 9,067 patients from 11 case–control studies, finding no association between sunscreen use and development of malignant melanoma. The only evidence suggesting a relationship between sunscreen and increased melanoma was correlational, and thus cannot be used to establish cause and effect.
Several studies with mice suggested that sunscreen failed to protect against melanoma, or even increased its incidence; but these were pre-2000 sunscreens that offered only limited protection against UVA radiation.
Authors who claim that sunscreen use causes melanoma have speculated that this occurs by one or more of the following mechanisms:
- the absence of UVA filters combined with a longer exposure time of the sunscreen user
- suppression of the skin's production of melanin, a natural broad-spectrum photoprotectant
- free radical generation by sunscreen chemicals that have penetrated into the skin
- cytotoxic and carcinogenic effects of nanoparticles
- carcinogenic effects of sunscreen ingredients related to vitamin A
Between 1% and 10% of some sunscreen ingredients are absorbed into the body through the skin. The absorption does not occur instantaneously, but the sunscreen concentration in the deeper levels of the skin increases over time. For this reason, the amount of time between the topical application of sunscreen and the end of the illumination period is an important parameter in experimental studies.
Although sunscreen ingredients are designed to block UV radiation that damages skin cells, some cell damage can be caused by the sunscreen ingredients themselves when absorbed into the skin and illuminated by sunlight. DNA, in particular, is susceptible to damage caused by photo-excited compounds. It is also well known that DNA alterations are necessary for cancer to occur. PABA causes DNA damage in human cells, and was banned as a sunscreen ingredient several years after these findings were published. Phenylbenzimidazole (PBI) causes DNA photodamage when illuminated while in contact with bacteria or human keratinocytes.
Studies have found that titanium dioxide nanoparticles cause genetic damage in mice when given orally in high doses. Nanoparticles are commonly used in American sunscreens to make them transparent on the skin; the EU has treated these with more caution, demanding they be treated like new chemicals, subject to safety assessments before being deployed in consumer products. In 2009, the EU initiated labeling requirements for nanoparticle ingredients in certain sunscreens and cosmetics.
Vitamin D deficiency
The use of even a weak sunscreen with SPF 8 inhibits more than 95% of vitamin D production in the skin, more effectively than it inhibits sunburn itself. Recent studies suggest that more Americans, Australians and New Zealanders are vitamin D deficient than previously thought. Ironically, there are indications that vitamin D deficiency may lead to higher cancer mortality. To avoid deficiency, dietary sources or vitamin supplements can be used, or adequate amounts of vitamin D can be produced with moderate sun exposure to the face, arms and legs, averaging 5–30 minutes twice per week without sunscreen. (The darker the complexion, the more minutes of exposure, approximating 25% of the time for minimal sunburn. Vitamin D overdose is impossible from UV exposure; the skin reaches an equilibrium where the vitamin degrades as fast as it is created.) If sunscreen slows vitamin D synthesis to just 5% of the normal rate, then normal production requires 20 times more exposure, from longer sessions, greater frequency and/or uncovered skin area.
Legal and regulatory issues
In 2006, a number of class-action lawsuits alleged that sunscreen manufacturers misled consumers into believing that these products provided full sun protection, while the products actually lacked effective UVA filters. The lawsuits were settled in 2009.
In 2007, the United States Food and Drug Administration "tentatively concluded that the available evidence fails to show that sunscreen use alone prevents skin cancer".
Sunscreen ingredients are not tested for photocarcinogenic effects in Europe, Japan or Australia before being introduced to the market. In the US, most sunscreens sold in 2008 have not passed regulatory testing either, due to a grandfather clause. Three new sunscreen active ingredients introduced in the US since 1978 have fulfilled new testing requirements.
- Ulrich, C; Degen, A; Patel, MJ; Stockfleth, E (2008). "Sunscreens in organ transplant patients". Nephrol Dial Transplant 23 (6): 1805–1808. doi:10.1093/ndt/gfn292. PMID 18492979.
- Ulrich, C; Hackethal, M; Ulrich, M; Forschner, T; Sterry, W; Stockfleth, E (2008). "Prevention of UV-induced infectious and malignant skin diseases in organ transplant patients by regular use of a liposomal sun screen". Berlin.
- Moloney FJ, Collins S, Murphy GM (2002). "Sunscreens: safety, efficacy and appropriate use". Am J Clin Dermatol 3 (3): 185–191. PMID 11978139.
- Lim, Henry W. "Quantum Leaps: New, Improved Sunscreens Have Arrived". The Skin Cancer Foundation. Retrieved December 21, 2014.
- Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ (July 2000). "Early detection and treatment of skin cancer". Am Fam Physician 62 (2): 357–368, 375–376, 381–382. PMID 10929700.
- Boring CC, Squires TS, Tong T (1991). "Cancer statistics, 1991". CA Cancer J Clin 41 (1): 19–36. doi:10.3322/canjclin.41.1.19. PMID 1984806.
- Farmer, KC; MF Naylor (1996). "Sun exposure, sunscreens, and skin cancer prevention: a year-round concern". Ann Pharmacother 30 (6): 662–673. PMID 8792954.
- Wang S, Setlow R, Berwick M, Polsky D, Marghoob A, Kopf A, Bart R (2001). "Ultraviolet A and melanoma: a review". J Am Acad Dermatol 44 (5): 837–846. doi:10.1067/mjd.2001.114594. PMID 11312434.
- Oliveria S, Saraiya M, Geller A, Heneghan M, Jorgensen C (2006). "Sun exposure and risk of melanoma". Arch Dis Child 91 (2): 131–138. doi:10.1136/adc.2005.086918. PMC 2082713. PMID 16326797.
- Green AC, Williams GM, Logan V, Strutton GM (January 2011). "Reduced melanoma after regular sunscreen use: randomized trial follow-up". J. Clin. Oncol. 29 (3): 257–263. doi:10.1200/JCO.2010.28.7078. PMID 21135266.
- The World Health Organization recommends that no person under 18 should use a sunbed
- Ainsleigh HG (1993). "Beneficial effects of sun exposure on cancer mortality". Prev Med. 22 (1): 132–140. doi:10.1006/pmed.1993.1010. PMID 8475009.
- Westerdahl J, Ingvar C, Mâsbäck A, Olsson H (July 2000). "Sunscreen use and malignant melanoma". Int. J. Cancer 87 (1): 145–150. doi:10.1002/1097-0215(20000701)87:1<145::AID-IJC22>3.0.CO;2-3. PMID 10861466.
- Autier P; Dore J F; Schifflers E; et al. (1995). "Melanoma and use of sunscreens: An EORTC case control study in Germany, Belgium and France". Int. J. Cancer 61 (6): 749–755. doi:10.1002/ijc.2910610602. PMID 7790106.
- Weinstock, M. A. (1999). "Do sunscreens increase or decrease melanoma risk: An epidemiologic evaluation". Journal of Investigative Dermatology Symposium Proceedings 4 (1): 97–100. doi:10.1038/sj.jidsp. PMID 10537017.
- Vainio H, Bianchini F (December 2000). "Cancer-preventive effects of sunscreens are uncertain". Scand J Work Environ Health 26 (6): 529–531. PMID 11201401.
- Wolf P, Quehenberger F, Müllegger R, Stranz B, Kerl H. (1998). "Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study". Melanoma Res. 8 (4): 370–378. doi:10.1097/00008390-199808000-00012. PMID 9764814.
- Graham S, Marshall J, Haughey B et al. (October 1985). "An inquiry into the epidemiology of melanoma". Am. J. Epidemiol. 122 (4): 606–619. PMID 4025303.
- Beitner H, Norell SE, Ringborg U, Wennersten G, Mattson B. (1990). "Malignant melanoma: aetiological importance of individual pigmentation and sun exposure". Br J Dermatol. 122 (1): 43–51. doi:10.1111/j.1365-2133.1990.tb08238.x. PMID 2297503.
- Garland C, Garland F, Gorham E (1992). "Could sunscreens increase melanoma risk?". Am J Public Health 82 (4): 614–615. doi:10.2105/AJPH.82.4.614. PMC 1694089. PMID 1546792.
- Huncharek M, Kupelnick B (July 2002). "Use of topical sunscreens and the risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies". Am J Public Health 92 (7): 1173–1177. doi:10.2105/AJPH.92.7.1173. PMC 1447210. PMID 12084704.
- Dennis LK, Beane Freeman LE, VanBeek MJ (December 2003). "Sunscreen use and the risk for melanoma: a quantitative review". Ann. Intern. Med. 139 (12): 966–978. doi:10.7326/0003-4819-139-12-200312160-00006. PMID 14678916.
- Wulf HC, Poulsen T, Brodthagen H, Hou-Jensen K (August 1982). "Sunscreens for delay of ultraviolet induction of skin tumors". J. Am. Acad. Dermatol. 7 (2): 194–202. doi:10.1016/S0190-9622(82)70108-2. PMID 6982289.
- Reeve VE; Greenoak GE; Gallagher CH; Canfield PJ; Wilkinson FJ (December 1985). "Effect of immunosuppressive agents and sunscreens on UV carcinogenesis in the hairless mouse". Aust J Exp Biol Med Sci 63 (6): 655–665. doi:10.1038/icb.1985.69. PMID 3879583.
- Flindt-Hansen, HP; Thune P, Larsen, TE (1990). "The inhibiting effect of PABA on photocarcinogenesis". Arch Dermatol Res 282 (1): 38–41. doi:10.1007/BF00505643. PMID 2317082.
- Wolf P, Donawho CK, Kripke ML (January 1994). "Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice". J. Natl. Cancer Inst. 86 (2): 99–105. doi:10.1093/jnci/86.2.99. PMID 8271307.
- Autier P, Boniol M, Doré JF (July 2007). "Sunscreen use and increased duration of intentional sun exposure: still a burning issue". Int. J. Cancer 121 (1): 1–5. doi:10.1002/ijc.22745. PMID 17415716.
- Gorham ED, Mohr SB, Garland CF, Chaplin G, Garland FC (December 2007). "Do sunscreens increase risk of melanoma in populations residing at higher latitudes?". Ann Epidemiol 17 (12): 956–963. doi:10.1016/j.annepidem.2007.06.008. PMID 18022535.
- Diffey BL (August 2005). "Sunscreens and melanoma: the future looks bright". Br. J. Dermatol. 153 (2): 378–381. doi:10.1111/j.1365-2133.2005.06729.x. PMID 16086753.
- Meredith, Paul; Riesz, Jennifer (2004). "Radiative Relaxation Quantum Yields for Synthetic Eumelanin". Photochemistry and photobiology 79 (2): 211–216. doi:10.1111/j.1751-1097.2004.tb00012.x. PMID 15068035.
- Hayden, C G J; Roberts, M S; Benson, H A E (1997). "Systemic absorption of sunscreen after topical application". The Lancet 350 (9081): 863–864. doi:10.1016/S0140-6736(05)62032-6. PMID 9310609.
- Walters, K. A.; Roberts, M. S. (2002). "Percutaneous absorption of sunscreens". Book: Bronaugh, R. L.; Maibach, H.I. Eds. Topical absorption of dermatological products. / New York: Dekker; 2002: 465–481.
- Treffel P, Gabard B (May 1996). "Skin penetration and sun protection factor of ultra-violet filters from two vehicles". Pharm. Res. 13 (5): 770–774. doi:10.1023/A:1016012019483. PMID 8860435.
- Hanson KM, Gratton E, Bardeen CJ (October 2006). "Sunscreen enhancement of UV-induced reactive oxygen species in the skin". Free Radic. Biol. Med. 41 (8): 1205–1212. doi:10.1016/j.freeradbiomed.2006.06.011. PMID 17015167.
- Mosley CN, Wang L, Gilley S, Wang S, Yu H (June 2007). "Light-induced cytotoxicity and genotoxicity of a sunscreen agent, 2-phenylbenzimidazole in Salmonella typhimurium TA 102 and HaCaT keratinocytes". Int J Environ Res Public Health 4 (2): 126–131. doi:10.3390/ijerph2007040006. PMID 17617675.
- Churg A, Gilks B, Dai J (November 1999). "Induction of fibrogenic mediators by fine and ultrafine titanium dioxide in rat tracheal explants". Am. J. Physiol. 277 (5 Pt 1): L975–L982. PMID 10564183.
- "The problem with vitamin A". Environmental Working Group. Retrieved December 22, 2014.
- National Toxicology Program (2012). NTP technical report on the photococarcinogenesis study of retinoic acid and retinyl palmitate in SKH-1 mice. Accessed September 19, 2013.
- Athanasia Varvaresou (2006). "Percutaneous absorption of organic sunscreens". Journal of Cosmetic Dermatology 5 (1): 53–57. doi:10.1111/j.1473-2165.2006.00223.x. PMID 17173572.
- Sheree E Cross; Ruoying Jiang; Heather A E Benson; Michael S Roberts (2001). "Can Increasing the Viscosity of Formulations be used to Reduce the Human Skin Penetration of the Sunscreen Oxybenzone?". Journal of Investigative Dermatology 117 (1): 147–150. doi:10.1046/j.1523-1747.2001.01398.x. PMID 11442762.
- E.Chatelain; B.Gabarda; C.Surber (2003). "Skin Penetration and Sun Protection Factor of Five UV Filters: Effect of the Vehicle" (PDF). Skin Pharmacol Appl Skin Physiol 16 (1): 28–35. doi:10.1159/000068291. PMID 12566826.
- "Sunscreens Can Damage Skin, Researchers Find", 29 August 2006
- R Jiang; M S Roberts; D M Collins; H A E Benson (October 1999). "Absorption of sunscreens across human skin: an evaluation of commercial products for children and adults". Br J Clin Pharmacol. 48 (4): 635–637. doi:10.1046/j.1365-2125.1999.00056.x. PMC 2014387. PMID 10583038.
- FDA (2000). Comments on Tentative Final Monograph for OTC Sunscreen Drug Products, Docket 78N-0038, Attachment F.
- N. J. Lowe, Physician's guide to sunscreen, Kap. 8, 1991.
- Xu, C.; Green, Adele; Parisi, Alfio; Parsons, Peter G (2001). "Photosensitization of the Sunscreen Octyl p-Dimethylaminobenzoate b UVA in Human Melanocytes but not in Keratinocytes". Photochemistry and Photobiology 73 (6): 600–604. doi:10.1562/0031-8655(2001)073<0600:POTSOP>2.0.CO;2. PMID 11421064.
- Knowland, John; McKenzie, Edward A.; McHugh, Peter J.; Cridland, Nigel A. (1993). "Sunlight-induced mutagenicity of a common sunscreen ingredient". FEBS Letters 324 (3): 309–313. doi:10.1016/0014-5793(93)80141-G. PMID 8405372.
- Damiani E, Greci L, Parsons R, Knowland J (April 1999). "Nitroxide radicals protect DNA from damage when illuminated in vitro in the presence of dibenzoylmethane and a common sunscreen ingredient". Free Radic. Biol. Med. 26 (7–8): 809–816. doi:10.1016/S0891-5849(98)00292-5. PMID 10232823.
- Long SD, Little JB (July 1984). "Sunscreen agents induce DNA repair activity in mouse embryo fibroblasts". J. Environ. Pathol. Toxicol. Oncol. 5 (4–5): 193–200. PMID 6520725.
- Stevenson, C.; Davies, R. J. H. (1999). "Photosensitization of guanine-specific DNA damage by 2-phenylbenzimidazole and the sunscreen agent 2-phenylbenzimidazole-5-sulfonic acid". Chem. Res. Toxicol. 12 (1): 38–45. doi:10.1021/tx980158l. PMID 9894016.
- Taylor CR, Stern RS, Leyden JJ, Gilchrest BA (January 1990). "Photoaging/photodamage and photoprotection". J. Am. Acad. Dermatol. 22 (1): 1–15. doi:10.1016/0190-9622(90)70001-X. PMID 2405022.
- Inbaraj, J. J.; Bilski, P.; Chignell, C. F. (2002). "Photophysical and photochemical studies of 2-phenylbenzimidazole and UVB sunscreen 2-phenylbenzimidazole-5-sulfonic acid". Photochem. Photobiol. 75 (2): 107–116. doi:10.1562/0031-8655(2002)075<0107:PAPSOP>2.0.CO;2. PMID 11883597.
- Elisabetta Damiani, Werner Baschong, Lucedio Greci (2007). "UV-Filter combinations under UV-A exposure: Concomitant quantification of over-all spectral stability and molecular integrity". Journal of Photochemistry and Photobiology B: Biology 87 (2): 95–104. doi:10.1016/j.jphotobiol.2007.03.003. PMID 17428672.
- Damiani E. Carloni P. Biondi C. Greci L. (2000). "Increased oxidative modification of albumin when illuminated in vitro in the presence of a common sunscreen ingredient: protection by nitroxide radicals – fractionated studies". Free Radical Biology and Medicine 28 (2): 193–201. doi:10.1016/S0891-5849(99)00221-X. PMID 11281286.
- J.M. Allen, C.J. Gosset, A.K. Allen (1996). "Photochemical formation of singlet molecular oxygen in illuminated aqueous solutions of several commercially available sunscreen ingredients". Chem. Res. Toxicol. 9 (3): 605–609. doi:10.1021/tx950197m. PMID 8728505.
- "Nanoparticles Used in Common Household Items Cause Genetic Damage in Mice". 17 November 2009. Retrieved 17 November 2009.
- McCutcheon, J (2014). Is Sunscreen Safe?
- Holick MF (December 2004). "Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease". Am. J. Clin. Nutr. 80 (6 Suppl): 1678S–1688S. PMID 15585788.
- Sayre, Robert M.; John C. Dowdy (2007). "Darkness at Noon: Sunscreens and Vitamin D3". Photochemistry and Photobiology 83 (2): 459–463. doi:10.1562/2006-06-29-RC-956. PMID 17115796.
- Zadshir A, Tareen N, Pan D, Norris K, Martins D (2005). "The prevalence of hypovitaminosis D among US adults: data from the NHANES III". Ethnicity & Disease 15 (4 Suppl 5): S5–97 – S5–101. PMID 16315387.
- Nowson C, Margerison C (2002). "Vitamin D intake and vitamin D status of Australians". Med J Aust 177 (3): 149–152. PMID 12149085.
- Grant WB (2002). "An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation". Cancer 94 (6): 1867–1875. doi:10.1002/cncr.10427. PMID 11920550.
- Holick, Michael F. (February 2002). "Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health". Current Opinion in Endocrinology, Diabetes and Obesity 9 (1): 87–98. doi:10.1097/00060793-200202000-00011.
- Holick MF (July 2007). "Vitamin D deficiency". The New England Journal of Medicine 357 (3): 266–281. doi:10.1056/NEJMra070553. PMID 17634462.
- Holick MF (September 2002). "Sunlight and Vitamin D". Journal of General Internal Medicine 17 (9): 733–735. doi:10.1046/j.1525-1497.2002.20731.x. PMC 1495109.
- "Lawsuit Filed Against Sunscreen Makers", 31 March 2006
- "Sunscreen Scare or Media Hype?", 29 June 2010
- FDA (2007). "Sunscreen Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph". Federal Register, 49079.
- Lautenschlager, Stephan; Wulf, Hans Christian; Pittelkow, Mark R. (2007). "photoprotection". Lancet 370 (9586): 528–537. doi:10.1016/S0140-6736(07)60638-2. PMID 17693182.